Send us a text with a question or thought on this episode ( We cannot replay from this link)
What if understanding how endometriosis builds its own blood supply could unlock safer, smarter treatment? We sit down with Professor Gaby Moawad—renowned robotic surgeon, educator, and leader in endometriosis care—to unpack the vascular engine that drives lesion growth, bleeding, and scarring. In five focused minutes, we translate complex molecular pathways into clear takeaways you can use to ask better questions and advocate for better care.
Dr. Moawad explains how hypoxia inside scarred tissue activates HIF alpha, which then boosts VEGF signaling to build new vessels. We explore how inflammation and locally produced estrogen amplify this process, why metalloproteinases (MMPs) cut space for vessels to form, and what immature pericytes have to do with leaky, bleeding lesions. He connects the dots from biology to the operating room: hypervascular lesions on MRI, the “powder burn” color changes created by hemosiderin, and the feedback loop that turns immune dysfunction into chronic pain and fibrosis.
We also touch on therapy frontiers. Anti-angiogenic drugs targeting VEGF show promise but raise concerns about wound healing and fertility. Dr. Moawad highlights where research is headed, including targeted delivery directly to lesions and cellular approaches that modulate endothelial progenitor cells. For anyone navigating diagnosis, imaging, fertility planning, or surgical decisions, this clear, science-backed overview offers a roadmap to discuss options with your care team and understand the trade-offs behind emerging treatments.
If this deep dive helped you see endometriosis through a sharper lens, follow the show, share it with someone who needs clarity, and leave a review so others can find it. Have a question you want answered fast? Send it our way and we’ll bring in the expert voice you need next.
Website endobattery.com
Quick Connect Format & Disclaimer
Alanna
0:00
Life
moves
fast,
and
so
should
the
answers
to
your
biggest
questions.
Welcome
to
Endo
Batteries
Quick
Connect,
your
direct
line
to
expert
insights.
Short,
powerful,
and
right
to
the
point.
You
send
in
the
questions,
I
bring
in
the
experts,
and
in
just
five
minutes,
you
get
the
knowledge
you
need.
No
long
episodes,
no
extra
time
needed.
And
just
remember,
expert
opinions
shared
here
are
for
general
information
and
not
for
personalized
medical
advice.
Always
consult
your
provider
for
your
case-specific
guidance.
Got
a
question?
Send
it
in,
and
let's
quickly
get
you
the
answers.
I'm
your
host,
Alanna,
and
it's
time
to
connect.
Guest Introduction
Alanna
0:41
Today's
guest
is
someone
who
is
truly
changing
the
landscape
of
endometriosis
care.
Professor
Gaby
Moawad
is
a
globally
recognized
leader
in
robotic
surgery
and
endometriosis
management.
He's
a
board-certified
gynecologic
surgeon
and
the
founder
of
the
Center
for
Endometriosis
and
Advanced
Pelvic
Surgery
in
Washington,
D.C.
Dr.
Moawad
has
dedicated
his
career
to
advancing
minimally
invasive
and
robotic
techniques,
combining
surgical
innovation
with
deep,
compassionate,
patient-centered
care.
As
director
of
robotic
gynecologic
surgery
and
associate
professor
at
George
Washington
University,
he's
trained
surgeons
worldwide
and
helped
redefine
how
we
approach
complex
pelvic
disease.
He's
been
named
Top
Doctor
in
Washington,
D.C.
for
nearly
a
decade
and
has
authored
over
125
peer-reviewed
publications
leading
global
conversations
on
endometriosis
and
surgical
innovation.
It's
an
honor
to
sit
down
and
welcome
a
true
pioneer
and
advocate
for
better
outcomes
for
women
everywhere.
Please
help
me
in
welcoming
Dr.
Gaby
Moawad.
How Endometriosis Builds Blood Supply
Alanna
1:56
And
lymphatic
pathways
and
how
they
might
actually
feed
or
spread
with
endometriosis.
Dr. Moawad
2:02
Well,
if
you
you're
looking
for
complexity,
here's
your
complex
answer.
So
there
are
there
are
a
few
substances
that
I
think
every
endometriosis
patient
should
at
least
try
to
remember
some
names
or
understand
what
they
do
in
endometriosis.
Every
endometriotic
cell
needs
oxygen
to
grow,
needs
nutrients
to
grow,
and
then
needs
blood
vessels
to
evacuate
their
waste.
This
is
part
of
almost
every
cell
in
the
body
rather
than
endometriosis
cells
only.
So
in
endometriosis
cells,
there
are
what
we
call
VEGF,
vascular
endothelial
growth
factor,
and
then
VEGF
receptors.
So
there
is
a
more
a
higher
prevalence
of
VEGF
that
help
producing
what
we
call
angiogenesis
and
vasculogenesis.
Angiogenesis
creating
new
blood
vessels.
So
those
lesions,
because
of
the
scarring
that
happens,
they
are
in
a
hypoxic
state
or
poor
oxygen
comes
there.
So
they
develop
what
we
call
hypoxia
induced
factor,
HIF
alpha.
That
what
this
produces,
it
upregulates
the
receptor
to
attract
more
VEGF
to
produce
more
blood
vessels.
So
that
HIF
is
a
substance
that
says,
I
don't
have
any
vessels
coming
to
bring
me
oxygen,
so
let's
bring
in
more
of
the
vascular
and
telial
growth
factor
so
they
produce
more
blood
vessels.
Now,
in
addition
to
that,
the
inflammatory
mediators,
interleukin
A,
Why Lesions Bleed And Change Color
Dr. Moawad
3:45
tumor
necrosis
factor,
they
also
promote
inflammation
and
increase
the
VEGF
in
the
endometriosis
cells.
So
you
can
see
how
the
circles
is
doing
things,
and
the
estrogen
is
present
in
high
concentration
in
endometriosis
lesions
because
there
is
the
aromatase.
They
produce
their
own
estrogen,
the
endometriosis
cells.
Now
add
to
this
through
all
that
concoction,
there
is
what
we
call
MMPs.
This
is
metalloproteinase.
These
are
substances
that
break
down
the
matrix
around
the
cells
for
endometriosis,
break
down
those
proteins
to
create
space
for
blood
vessels
to
form.
So
now
we
see
all
those
blood
vessels
have
space
to
form,
they
start
forming.
And
we
can
see
a
higher
density
even
on
imaging
of
endometriosis
lesions
when
we
do
the
contrast
on
MRI,
they're
hypervascularized.
Now,
throughout
that
whole
medium,
what
happens?
Those
inflammation
start
promoting
the
bone
marrow
to
produce
EPCs,
EPC
endothelial
progenitor
cells.
So
these
are
cells
that
come
and
shear
lead
the
formation
of
vessels.
So
you
have
a
higher
number
of
those
cells,
so
everybody
is
engaged
to
produce
more
vessels
in
the
endometriosis
lesions.
Then
we
do
say,
oh,
endometriosis
lesions
bleeds.
Why?
Because
there
is
on
every
blood
vessel
a
lining
of
cells.
We
can
call
them
pericytes.
Peri
means
near,
they
lines,
those
sites
mean
cells,
they
line
the
blood
vessels.
So
there
is
an
immature
support
of
those
pericytes.
That's
why
those
blood
vessels
are
leaky,
and
that's
why
they
they
tend
to
leak
blood
outside,
and
that's
what
they
bleed.
So
you
can
see
how
that
angiogenesis
or
the
formation
of
blood
vessel
is
led
by
inflammation,
by
hyperestrogenism,
local
hyperestrogenism
in
the
lesions,
by
all
those
substances
created
to
promote
from
the
body,
from
the
bone
marrow,
to
promote
further
formations
of
immature
cells
that
leads
to
bleeding
and
then
engage
further
the
body
to
inflame
more.
Alanna
6:12
Is
that
why
we
get
variation
in
color
for
the
lesions
as
well?
Dr. Moawad
6:18
Yes,
yes,
yes,
yes.
Alanna
6:19
And
you
know,
we
hear
about
the
powder
burn
lesions,
but
there's
also
a
rainbow
of
color
in
lesions.
Dr. Moawad
6:26
So
when
the
blood
leaks
from
those
vessels,
it
is
digested
by
the
enzymes,
and
they're
part
of
the
metabolites
of
the
digestion
is
hemofiderin,
and
they
deposit
there,
and
it
gives
the
color
of
purple
or
powder
burn
lesion.
And
then
you
can
have
a
different
level
of
vascular
or
scarring
because
whenever
you
produce
inflammation,
your
body
reacts
to
scarring.
And
since
we
have
an
immune
dysfunction
with
endometriosis,
so
the
scarring
is
there
is
an
over-reaction
to
the
inflammation
with
extensive
scarring.
Targeted Therapies And Research Directions
Alanna
6:59
Yeah.
Dr. Moawad
7:00
So
it's
mostly
really
well
understood
on
the
molecular
level,
and
this
is
help
us
a
lot
in
trying
to
figure
out
therapeutic
approaches.
So
there
have
been
trials
that
did
target
the
VEGF
or
anti-angiogenic
therapeutic
medication.
These
showed
promising
results,
but
they
led
to
poor
wound
healing,
and
then
their
impact
on
fertility
is
unknown.
So
further
study
maybe
about
the
delivery
method
of
those
substances,
maybe
direct
delivery
through
the
lesions,
might
help
improving
with
minimizing
the
systemic
side
effects.
So
when
we
understand
what's
causing
what,
we
can
further
our
research
to
try
to
help
through
targeted
therapies
or
cellular
therapies
for
endometriosis.
Closing And How To Submit Questions
Alanna
7:53
That's
a
wrap
for
this
quick
connect.
I
hope
today's
insights
helped
you
move
forward
with
more
clarity
and
confidence.
Do
you
have
more
questions?
Keep
them
coming.
Send
them
in,
and
I'll
bring
you
the
expert
answers.
You
can
send
them
in
by
using
the
link
in
the
top
of
the
description
of
this
podcast
episode
or
by
emailing
contact
at
Indobattery.com
or
visiting
the
Indobattery.com
contact
page.
Until
next
time,
keep
feeling
empowered
through
knowledge.
